AQR CAPITAL MANAGEMENT LLC
Position in AMLX — Amylyx Pharmaceuticals, Inc.
CIK 1167557
Greenwich, CT
Position in AMLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$404,335
+$67,944 QoQ
Shares Held
29,089
+4.5% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026AQR CAPITAL MANAGEMENT LLC holds $1,491,893,072 across 43 Drug Manufacturers - Specialty & Generic names. AMLX ranks #37 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
4,938,967 | $650,659,508 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
826,226 | $489,935,489 | |
| 3 | VTRS |
Viatris Inc
|
6,341,318 | $85,671,200 | |
| 4 | ZTS |
Zoetis Inc.
|
607,950 | $71,865,765 | |
| 5 | IRWD |
Ironwood Pharmaceuticals Inc
|
7,535,080 | $26,448,126 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
378,697 | $18,234,258 | |
| 7 | TAK |
Takeda Pharmaceutical Co Ltd
|
894,423 | $16,564,712 | |
| 8 | ALKS |
Alkermes plc.
|
383,977 | $13,577,424 |
All Filings in AMLX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $404,335 | 29,089 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $336,391 | 27,847 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $1,000,765 | 73,640 | Shares | Other | 2025-11-14 | |
| 2024-12-31 | $712,099 | 188,386 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $2,103,015 | 649,079 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $6,347,790 | 3,340,943 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $330,827 | 116,489 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $343,623 | 23,344 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $432,830 | 23,639 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $306,962 | 14,231 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $230,230 | 7,847 | Shares | Defined | 2023-05-15 | |
| No filing history on record for this holder in this stock. | ||||||